Healthcare -
Biotechnology - NASDAQ - US
$ 3.6301
4.61 %
$ 2.65 B
Market Cap
-4.03
P/E
IBRX - NET CHANGE IN CASH
Net Change in Cash IBRX - ImmunityBio, Inc.
161 M
LAST VALUE
4.89%
2 YEAR CAGR
90.07%
5 YEAR CAGR
92.18%
10 YEAR CAGR